SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001140361-21-011655
Filing Date
2021-04-05
Accepted
2021-04-05 17:25:56
Documents
2
Group Members
CELGENE CORP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G brhc10022780_sc13g.htm SC 13G 93930
2 JOINT FILING AGREEMENT brhc10022780_ex99-1.htm EX-99.1 5643
  Complete submission text file 0001140361-21-011655.txt   101234
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Filed by) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Subject) CIK: 0001835579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92449 | Film No.: 21806748
SIC: 2836 Biological Products, (No Diagnostic Substances)